Lataa...
Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia
New treatments for adults with acute lymphoblastic T-cell leukemia (T-ALL) are urgently needed, as the current rate of overall remission in these patients is only about 40 percent. We recently showed the potential therapeutic benefit of the pegylated-human-arginase I (peg-Arg I) in T-ALL. However, t...
Tallennettuna:
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3594435/ https://ncbi.nlm.nih.gov/pubmed/22926702 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2012.247 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|